PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 9, 2025Frontiers in Psychiatry2 citationsOpen Access

Impact of comorbid depression on quality of life and disease progression in chronic obstructive pulmonary disease: a correlational analysis

View Full Paper
YCYu ChenQGQianqian GaoHJHongqin Jia

Key Points

  • Patients with comorbid depression experienced a notable decline in quality of life and disease progression during acute exacerbations.
  • Among 269 AECOPD patients, those with greater disease severity and perceived stigma were more susceptible to depression.
  • Data collection utilized WHOQOL-BREF and other assessment tools, highlighting key risk factors for depression in COPD.
  • Findings emphasize the importance of addressing comorbid depression to improve management and outcomes in COPD patients.

Abstract

Introduction Depression is a prevalent comorbidity in patients with Chronic Obstructive Pulmonary Disease (COPD), particularly during acute exacerbations (AECOPD), significantly impacting prognosis and quality of life. This study aimed to investigate the risk factors and severity of depression in this population. Objective To identify risk factors and assess depression severity in patients experiencing Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). Methods AECOPD patients admitted to Chaohu Hospital Affiliated with Anhui Medical University, between October 2023 and February 2025 were included. Participants were divided into four groups using the Patient Health Questionnaire-9 (PHQ-9): mild depression group (n=86), moderate depression group (n=24), severe depression group (n=3), and a control group without depression (n=156). Data collection involved: the first two domains of the World Health Organization Quality of Life questionnaire (WHOQOL-BREF), The Social Impact Scale (SIS) for stigma assessment Clinical data, treatment history, and laboratory test results. A custom-designed questionnaire was utilized to record hospitalization details for intergroup comparisons. Results This study included 269 AECOPD patients, comprising 113 cases in the depression group and 156 controls. Comparative analysis revealed that female patients, those with longer smoking histories, theophyllines users, individuals with greater disease severity, stronger perceived stigma, and poorer quality of life demonstrated higher susceptibility to depression. In depression severity subgroups, 86 cases were classified as mild depression while 27 cases exhibited moderate-to-severe depression. The results demonstrated that gender, glucocorticoid use, daily cigarette consumption, and prolonged hospitalization were significantly associated with aggravated comorbid depression in COPD patients. Conclusion Depressive state in patients with AECOPD is clinically common and associated with factors including gender, smoking history, MMRC grade, disease severity, hospitalization duration, theophyllines use, as well as quality of life and stigma.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68e7ba40ccde5f1021f64a9ehttps://doi.org/10.3389/fpsyt.2025.1667902
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Occurrence of Anxiety and Depression among Stable COPD Patients and its Impact on Functional Capability2017 · 42 citations
  2. 2Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies2024 · 21 citations
  3. 3Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease2014 · 247 citations
  4. 4Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles2009 · 475 citations
  5. 5Serotonin reuptake inhibitors augmentation with cariprazine in patients with treatment-resistant obsessive-compulsive disorder: a retrospective observational study2024 · 13 citations